Clinical Trials Logo

Clinical Trial Summary

A Clinical Trial to evaluate the Pharmacokinetics and safety of CKD-344


Clinical Trial Description

A Phase 1 Clinical Trial to evaluate the safety and pharmacokinetics in healthy adult volunteers after administration of CKD-344. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04867200
Study type Interventional
Source Chong Kun Dang Pharmaceutical
Contact Yook-Hwan Noh, M.D., PhD.
Phone +82-70-4665-9174
Email yook.noh@gmail.com
Status Recruiting
Phase Phase 1
Start date April 27, 2021
Completion date June 1, 2021

See also
  Status Clinical Trial Phase
Recruiting NCT04010955 - Adding Antiplatelet During Edoxaban Treatment in Stroke Patients With Non-valvular Atrial Fibrillation (ADD-ON)
Recruiting NCT04673695 - A Clinical Study to Evaluate the Safety and Pharmacokinetics of CKD-344 Phase 1
Completed NCT03893591 - A Prospective Study to Examine the Need to Adjust the Dose of Apixaban When Used in Atrial Fibrillation and Obesity
Completed NCT03895502 - Optimal Duration of Anticoagulation Therapy for Isolated Distal Deep Vein Thrombosis in Patients With Cancer Study Phase 4
Completed NCT03154489 - Effectiveness of a Multidisciplinary Medication Review With Follow-up for Patients Treated With Coumarin Anticoagulants in Primary Care N/A
Completed NCT04305821 - Medico-economic Interest of the Protein S100b in Mild Head Trauma Under Anti-thrombotics
Recruiting NCT06020560 - Study of Low Molecular Weight Heparins Phase 4
Not yet recruiting NCT05788913 - Evaluation of the Pharmacodynamics of a Heparin With Its Biological Comparator, Subcutaneous Administration Phase 1
Not yet recruiting NCT05788900 - Evaluation of the Pharmacodynamics of a Heparin With Its Biological Comparator, Intravenous Administration Phase 1
Terminated NCT03172546 - Determinants of Oral Anticoagulants' Activity
Not yet recruiting NCT04592822 - A Single Dose Bioequivalence Study of WD-1602 Versus Pradaxa® in Healthy Subjects Under Fed Condition Phase 1
Recruiting NCT03772457 - Predictive Value of Infarction Volume on Hemorrhagic Transformation in Ischemic Stroke/TIA With Non-valve Atrial Fibrillation(NVAF) Patients Using Rivaroxaban
Completed NCT03323320 - Evaluation of Patient's Knowledge of Their NACO Treatment N/A
Recruiting NCT04257487 - Sulodexide, VESSEL®, for the Prevention of Recurrent Venous Thromboembolism (The Jason Study) Phase 3
Completed NCT04272723 - Management of Venous Thromboembolism in France: a National Survey Among Vascular Medicine Physicians